id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-0931-0004,FDA,FDA-2022-E-0931,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-11-09T05:00:00Z,2022,11,2022-11-09T05:00:00Z,,2022-11-09T21:52:01Z,,0,0,090000648549f71a
FDA-2022-E-0931-0003,FDA,FDA-2022-E-0931,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-09-28T04:00:00Z,2022,9,2022-09-28T04:00:00Z,,2022-09-28T20:07:53Z,,0,0,090000648537b97c
FDA-2022-E-0931-0001,FDA,FDA-2022-E-0931,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-05-27T04:00:00Z,2022,5,2022-05-27T04:00:00Z,,2022-05-27T18:17:14Z,,0,0,09000064850ff6b4
FDA-2022-E-0931-0002,FDA,FDA-2022-E-0931,"Patent Extension Application from McCarter & English LLP (on behalf of The Regents of the University of Michigan, Progeria Research Foundation,, Inc and The University of North Carolina at Chapel Hill)",Other,Application,2022-05-27T04:00:00Z,2022,5,2022-05-27T04:00:00Z,,2022-05-27T18:17:31Z,,0,0,09000064850ff6b6